DNA-sequence patenting: National Society of Genetic Counselors (NSGC) position paper |
| |
| Authors: | McIntosh Nathalie,Braddock Bonnie R,Branda Kelly J,Eanet Karen,Goldberg Simon,Kieffer Stephanie A,Primiano Lisa,Quercia Nada,Taylor Kelly A,Tsipis Judith,Yashar Beverly M,Yesley Anne National Society of Genetic Counselors DNA Sequence Patenting Position Paper Working Group |
| |
| Affiliation: | (1) Department of Biology, Brandeis University, Waltham, Massachusetts;(2) Section of Genetics, Upstate Medical University, Syracuse, New York;(3) Dana Farber Cancer Institute, Boston, Massachusetts;(4) Greater Baltimore Medical Center, Harvey Institute of Human Genetics, Baltimore, Maryland;(5) American Medical Association, Chicago, Illinois;(6) Clinical Genetics, University of Alberta Hospital, Edmonton, Canada;(7) Office of Technology Licensing, Stanford University, Palo Alto, California;(8) Division of Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Canada;(9) Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee;(10) Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan;(11) Athena Diagnostics, Inc., Worcester, Massachusetts |
| |
| Abstract: | In November 2000, the Genetic Services Committee of the National Society of Genetic Counselors (NSGC) convened a working group to draft a position paper on patenting of DNA-sequences. The mandate of the group was to produce general position statements that support the perspective and needs of consumers of DNA-based genetic tests and therapies (our patients and their families) and participants in DNA-based genetic research. After review and discussion of the literature on DNA-sequence patenting issues, the working group drafted position statement points that support current United States Patent and Trademark Office (USPTO) guidelines; broad licensing of DNA-sequence patents; nonenforcement of DNA-sequence patents in noncommercial research; reasonable royalty rates; an informed consent process for research participants that discloses whether they can share in any financial rewards relating to the project; the development of guidelines for licensing of DNA-sequence patents; and the establishment of oversight organizations to monitor licensing of DNA-sequence patents. These position statements were approved by the NSGC Board of Directors in the fall of 2001. |
| |
| Keywords: | patenting DNA-sequence position paper licensing royalties genetic testing genetic therapies National Society of Genetic Counselors (NSGC) |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
